Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.

Abstract: The present disclosure generally relates to a fluid container (100) for holding a fluid, specifically adapted for improved user handling by reducing the risk of fluid spillage in combination with easy extraction of the fluid comprised in the container (100). The fluid container (100) comprises a flap portion (110), which in its down-folded state allows for a predetermined amount of liquid to be stored in the container without the risk of leakage, and which flap-portion (110) in its up-folded state allows for easy extraction of fluid from the container (100). The present disclosure also relates to a fluid container system.

Abstract: The present invention relates to a suction device. The suction device comprises an attachment portion adapted to be attached to a wound cover member. The suction device comprises a fluid inlet which is at least partially circumscribed by the attachment portion. The suction device also comprises a fluid outlet. The suction device further comprising a connection portion adapted to, at least during one operation condition of the suction device, provide a fluid communication between the fluid inlet and the fluid outlet. The connection portion comprises an inspection portion that is transparent to thereby facilitate the positioning of the suction device relative to the wound cover member.

Abstract: A medical dressing is provided. The dressing has a central portion and a border portion, and comprises a backing layer, an adhesive body contact layer and a pad arranged in the central portion between the backing layer and the adhesive body contact layer. The pad is symmetric about a longitudinal center line and the dressing comprises a lobed portion on each side of the center line. The medical dressing comprises a gripping tab which is coplanar with the border portion and which projects outwardly from the border portion. The medical dressing may be used for pressure ulcer prevention, such as at the sacrum region of a human body.

Abstract: Undue scarring of healing wounds is decreased and/or the relapse rate of wounds is lowered by applying a composition that includes hemoglobin to the wound area. At least 40% of the hemoglobin in the composition is provided in CO-charged form.

Abstract: The present disclosure relates to a patient support which can be used in a bed or flat surface and in particular to a system and method for support and offloading of the body and for turning and repositioning of a patient in a bed or on a flat surface. Features of the disclosure also relate to markings and other indicators used on the patient support which help guide caregivers in the proper use and correct patient positioning on the patient support.

Abstract: The present invention relates to a composite material, which is of particular use in wound treatment, and to a method for producing the same composite material. Said composite material comprises a hydrophilic polyurethane foam material comprising a first polyurethane polymer; a hydrophilic fiber material comprising a second polymer, wherein said second polymer is not a polyurethane polymer and wherein said fiber material is capable of absorbing and retaining a fluid. In the composite material according to the present invention, said first polymer is covalently bonded to said second polymer.

Abstract: The present invention relates to a wound pad comprising fibers and being provided with at least a first and a second discrete group of incisions, wherein each one of said discrete groups of incisions comprises at least a first and a second incision, wherein said first and said second incision extend from a common starting point to a respective end point, wherein the end point of said first incision is spaced from the end point of said second incision, wherein the common starting point of said first group of incisions is provided on a first side of an imaginary line extending in the machine direction of said fibrous wound pad, and the common starting point of said second group of incisions is provided on a second side of said imaginary line, and wherein a first incision of said first group of incisions and a second incision of said second group of incisions each cross said imaginary line. The present invention also relates to a self-adhesive member for adhering to and cover a portion of a user's skin.

Abstract: The invention relates to a wound care product, comprising a wound care article located in a sterilized sealed chamber defining a sterile environment. The wound care product also comprises an openable and reclosable container which has at least one outer surface portion in said sterile environment. The invention further relates to a method for using such a wound care product.

Abstract: Undue scarring of healing wounds is decreased and/or the relapse rate of wounds is lowered by applying a composition that includes hemoglobin to the wound area. At least 40% of the hemoglobin in the composition is provided in CO-charged form.

Abstract: A medical dressing (30) is disclosed, comprising an adhesive layer (3) having a skin-facing surface (6) to adhere the medical dressing to a dermal surface, wherein said adhesive layer comprises a first chemical compound incorporated within said adhesive layer, and wherein at least a portion of said skin-facing surface comprises a coating (9) comprising a second chemical compound. Also disclosed is a method of manufacturing such a medical dressing.

Abstract: A wound dressing comprises a wound pad and a backing layer on a non-wound facing side of the backing layer. At least a portion of a sealing ring is provided within 5 mm of and continuously along the contour of the wound pad. A negative pressure wound treatment system comprising such a wound dressing is also disclosed.

Abstract: A silicone foam is described that is produced in-situ at a wound site, e.g. in a wound cavity, through a multi-component system, based on a physical foaming process, wherein the gas required to form the foam structure is provided through a blowing agent independently of the curing reaction of polyorganosiloxane components of the multi-component system. Therefore, the blowing agent is provided as a distinct entity of the multi-component system that is, in particular, not the result of any chemical reaction taking place in the multi-component system. A device for producing the foam and the corresponding negative pressure wound therapy kit are also described.

Abstract: Undue scarring of healing wounds is decreased and/or the relapse rate of wounds is lowered by applying a composition that includes hemoglobin to the wound area. At least 90% of the hemoglobin in the composition is provided in CO-charged form.

Abstract: The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.